Q4 2024 · 13F-HR
Indaba Capital Management, L.P.holdings as filed
Filed 2025-02-14 · accession 0001011438-25-000175
$207.5M
Reported value
10
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 69122G102 | — | BLUE OWL CAP CORP III | $40.3M | 19.4% | 2,793,366 | Common | SOLE |
| 05988JAD5 | BAND 0.5 04/01/28 | BANDWIDTH INC | $32.2M | 15.5% | 40,250,000 | Common | SOLE |
| 68339B104 | ONTF | ON24 INC | $27.4M | 13.2% | 4,240,256 | Common | SOLE |
| 761330AB5 | RVNC 1.75 02/15/27 | REVANCE THERAPEUTICS INC | $24.0M | 11.6% | 25,000,000 | Common | SOLE |
| 866082AA8 | INN 1.5 02/15/26 | SUMMIT HOTEL PPTYS | $22.0M | 10.6% | 22,664,000 | Common | SOLE |
| 294628102 | HP5A | EQUITY COMWLTH | $16.9M | 8.14% | 9,550,000 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $13.0M | 6.28% | 14,000,000 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $12.8M | 6.18% | 13,000,000 | Common | SOLE |
| 00430HAC6 | — | ACCELERATE DIAGNOSTICS INC | $12.3M | 5.95% | 24,685,998 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $6.6M | 3.18% | 3,000,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.